Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katzenstein

Showing results (601-610 of 874) with videos related to

Pageof 88
Sort By:
Pediatric Blood & Cancer|July 27, 2010
Intracavitary cisplatin therapy for pediatric malignanciesHoward M Katzenstein, Sarah Petricca, Richard Ricketts, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2000
Effectiveness of the angiogenesis inhibitor TNP-470 in reducing the growth of human neuroblastoma in nude mice inversely correlates with tumor burdenH M Katzenstein, A W Rademaker, C Senger, et al.
AIDS (London, England)|May 11, 2010
Viremia and drug resistance among HIV-1 patients on antiretroviral treatment: a cross-sectional study in Soweto, South AfricaZiad El-Khatib, Anna Mia Ekstrom, Johanna Ledwaba, et al.
Plos One|March 27, 2015
Nevirapine, sodium concentration and HIV-1 RNA in breast milk and plasma among HIV-infected women receiving short-course antiretroviral prophylaxisKirsten Salado-Rasmussen, Zahra P Theilgaard, Mercy G Chiduo, et al.
AIDS Research and Therapy|August 4, 2011
Addressing the fear and consequences of stigmatization - a necessary step towards making HAART accessible to women in Tanzania: a qualitative studyZahra P Theilgaard, Terese L Katzenstein, Mercy G Chiduo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 3, 2000
Differences between women and men in adverse events and CD4+ responses to nucleoside analogue therapy for HIV infection. The Aids Clinical Trials Group 175 TeamJ S Currier, C Spino, J Grimes, et al.
Sarcoma|March 2, 2017
Correlation of Ezrin Expression Pattern and Clinical Outcomes in Ewing SarcomaThomas Cash, Hong Yin, Courtney McCracken, et al.
Open Forum Infectious Diseases|March 14, 2019
Persistence of Human Immunodeficiency Virus-1 Drug Resistance Mutations in Proviral Deoxyribonucleic Acid After Virologic Failure of Efavirenz-Containing Antiretroviral RegimensJustin De La Cruz, Saran Vardhanbhuti, Malaya K Sahoo, et al.
International Journal of STD & AIDS|November 24, 2005
The feasibility of voluntary counselling and HIV testing for pregnant women using community volunteers in ZimbabweAvinash K Shetty, Miriam Mhazo, Sostain Moyo, et al.
HIV Clinical Trials|May 18, 2007
Non-nucleoside phenotypic hypersusceptibility cut-point determination from ACTG 359Richard H Haubrich, Hongyu Jiang, Ronald Swanstrom, et al.
Pageof 88

Showing results (601-610 of 874) with videos related to

Sort By:
Pageof 88
Pediatric Blood & Cancer|July 27, 2010
Intracavitary cisplatin therapy for pediatric malignanciesHoward M Katzenstein, Sarah Petricca, Richard Ricketts, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2000
Effectiveness of the angiogenesis inhibitor TNP-470 in reducing the growth of human neuroblastoma in nude mice inversely correlates with tumor burdenH M Katzenstein, A W Rademaker, C Senger, et al.
AIDS (London, England)|May 11, 2010
Viremia and drug resistance among HIV-1 patients on antiretroviral treatment: a cross-sectional study in Soweto, South AfricaZiad El-Khatib, Anna Mia Ekstrom, Johanna Ledwaba, et al.
Plos One|March 27, 2015
Nevirapine, sodium concentration and HIV-1 RNA in breast milk and plasma among HIV-infected women receiving short-course antiretroviral prophylaxisKirsten Salado-Rasmussen, Zahra P Theilgaard, Mercy G Chiduo, et al.
AIDS Research and Therapy|August 4, 2011
Addressing the fear and consequences of stigmatization - a necessary step towards making HAART accessible to women in Tanzania: a qualitative studyZahra P Theilgaard, Terese L Katzenstein, Mercy G Chiduo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 3, 2000
Differences between women and men in adverse events and CD4+ responses to nucleoside analogue therapy for HIV infection. The Aids Clinical Trials Group 175 TeamJ S Currier, C Spino, J Grimes, et al.
Sarcoma|March 2, 2017
Correlation of Ezrin Expression Pattern and Clinical Outcomes in Ewing SarcomaThomas Cash, Hong Yin, Courtney McCracken, et al.
Open Forum Infectious Diseases|March 14, 2019
Persistence of Human Immunodeficiency Virus-1 Drug Resistance Mutations in Proviral Deoxyribonucleic Acid After Virologic Failure of Efavirenz-Containing Antiretroviral RegimensJustin De La Cruz, Saran Vardhanbhuti, Malaya K Sahoo, et al.
International Journal of STD & AIDS|November 24, 2005
The feasibility of voluntary counselling and HIV testing for pregnant women using community volunteers in ZimbabweAvinash K Shetty, Miriam Mhazo, Sostain Moyo, et al.
HIV Clinical Trials|May 18, 2007
Non-nucleoside phenotypic hypersusceptibility cut-point determination from ACTG 359Richard H Haubrich, Hongyu Jiang, Ronald Swanstrom, et al.
Pageof 88